Role of toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome

Arthritis and Rheumatology

Volumn 66, Issue 11, 2014, Pages 3210-3220

  Benhamou, Ygal ^a   Bellien, Jeremy ^a   Armengol, Guillaume ^a   Brakenhielm, Ebba ^b   Adriouch, Sahil ^b   Iacob, Michele ^a   Remy Jouet, Isabelle ^b   Le Cam Duchez, Véronique ^a   Monteil, Christelle ^b   Renet, Sylvanie ^b   Jouen, Fabienne ^b   Drouot, Laurent ^b   Menard, Jean François ^a   Borg, Jeanne Yvonne ^a   Thuillez, Christian ^a   Boyer, Olivier ^b   Levesque, Hervé ^a   Richard, Vincent ^a   Joannidès, Robinson ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MESSENGER RNA; NITRIC OXIDE; PHOSPHOLIPID ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANTIPHOSPHOLIPID SYNDROME; ARRTERIAL FUNCTION; ARTERIAL REMODELING; ARTERIAL STIFFNESS; ARTERIAL STRUCTURE; ARTERIAL WALL THICKNESS; ARTERY DISEASE; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHY; KNOCKOUT MOUSE; LIPID PEROXIDATION; MALE; MEDICAL ASSESSMENT; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY ARTERIAL ANTIPHOSPHOLIPID SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; WILD TYPE; AGED; ANIMAL; C57BL MOUSE; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CELL CULTURE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR REMODELING; VASODILATATION;

ADULT; AGED; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BRACHIAL ARTERY; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PULSE WAVE ANALYSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VASCULAR REMODELING; VASODILATION;

EID: 84925581582     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38785     Document Type: Article

References (50)

1. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA,. Antiphospholipid syndrome. Lancet 2010; 376: 1498-509.
2. Hughes GR,. Hughes syndrome (the antiphospholipid syndrome): ten clinical lessons. Autoimmun Rev 2008; 7: 262-6.
3. Christodoulou C, Sangle S, D'Cruz DP,. Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome. Rheumatology (Oxford) 2007; 46: 907-10.
4. Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, et al., Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009; 68: 1428-32.
5. Charakida M, Besler C, Batuca JR, Sangle S, Marques S, Sousa M, et al., Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA 2009; 302: 1210-7.
6. Ames PR, Margarita A, Alves JD,. Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rev Allergy Immunol 2009; 37: 29-35.
7. Belizna CC, Richard V, Primard E, Kerleau JM, Cailleux N, Louvel JP, et al., Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding. Semin Arthritis Rheum 2008; 37: 373-80.
8. Cugno M, Borghi MO, Lonati LM, Ghiadoni L, Gerosa M, Grossi C, et al., Patients with antiphospholipid syndrome display endothelial perturbation. J Autoimmun 2010; 34: 105-10.
9. Pierangeli SS, Colden-Stanfield M, Liu X, Barker JH, Anderson GL, Harris EN,. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997-2002.
10. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, et al., Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 2007; 56: 2687-97.
11. Simoncini S, Sapet C, Camoin-Jau L, Bardin N, Harle JR, Sampol J, et al., Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome. Int Immunol 2005; 17: 489-500.
12. Drexler SK, Foxwell BM,. The role of Toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010; 42: 506-18.
13. Benhamou Y, Favre J, Musette P, Renet S, Thuillez C, Richard V, et al., Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice. Crit Care Med 2009; 37: 1724-8.
14. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, et al., Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 2007; 27: 1064-71.
15. Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, et al., Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003; 171: 1473-83.
16. Allen KL, Fonseca FV, Betapudi V, Willard B, Zhang J, McCrae KR,. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. Blood 2011; 119: 884-93.
17. Satta N, Kruithof EK, Fickentscher C, Dunoyer-Geindre S, Boehlen F, Reber G, et al., Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood 2011; 117: 5523-31.
18. Xie H, Zhou H, Wang H, Chen D, Xia L, Wang T, et al., Anti-β2GPI/β2GPI induced TF and TNF-α expression in monocytes involving both TLR-4/MyD88 and TLR-4/TRIF signaling pathways. Mol Immunol 2013; 53: 246-54.
19. Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, et al., Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003; 101: 3495-500.
20. Pierangeli SS, Vega-Ostertag ME, Raschi E, Liu X, Romay-Penabad Z, De Micheli V, et al., Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 2007; 66: 1327-33.
21. Joannides R, Monteil C, de Ligny BH, Westeel PF, Iacob M, Thervet E, et al., Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant 2011; 11: 2414-22.
22. Maltete D, Bellien J, Cabrejo L, Iacob M, Proust F, Mihout B, et al., Hypertrophic remodeling and increased arterial stiffness in patients with intracranial aneurysms. Atherosclerosis 2012; 211: 486-91.
23. Bellien J, Iacob M, Remy-Jouet I, Lucas D, Monteil C, Gutierrez L, et al., Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. Circulation 2012; 125: 1266-75.
24. Dasu MR, Devaraj S, Park S, Jialal I,. Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010; 33: 861-8.
25. Banquet S, Gomez E, Nicol L, Edwards-Levy F, Henry JP, Cao R, et al., Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 2011; 124: 1059-69.
26. Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, et al., Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum 2011; 63: 1961-71.
27. Belizna C, Lartigue A, Favre J, Gilbert D, Tron F, Levesque H, et al., Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome? Lupus 2008; 17: 185-94.
28. Pengo V, Ruiz-Irastorza G, Denas G, Andreoli L, Khamashta M, Tincani A,. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS.' Autoimmun Rev 2012; 11: 577-80.
29. Mercanoglu F, Erdogan D, Oflaz H, Kucukkaya R, Selcukbiricik F, Gul A, et al., Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome. Int J Clin Pract 2004; 58: 1003-7.
30. Gresele P, Migliacci R, Vedovati MC, Ruffatti A, Becattini C, Facco M, et al., Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. Thromb Res 2009; 123: 444-51.
31. Forastiero RR, Martinuzzo ME, de Larranaga GF,. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 2005; 14: 129-36.
32. Swadzba J, Iwaniec T, Musial J,. Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol Int 2011; 31: 307-13.
33. Zhou H, Wolberg AS, Roubey RA,. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004; 104: 2353-8.
34. Ferro D, Saliola M, Meroni PL, Valesini G, Caroselli C, Pratico D, et al., Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost 2003; 1: 523-31.
35. Ames PR, Nourooz-Zadeh J, Tommasino C, Alves J, Brancaccio V, Anggard EE,. Oxidative stress in primary antiphospholipid syndrome. Thromb Haemost 1998; 79: 447-9.
36. Delgado Alves J, Mason LJ, Ames PR, Chen PP, Rauch J, Levine JS, et al., Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model. Rheumatology (Oxford) 2005; 44: 1238-44.
37. Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G, et al., Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J Clin Invest 2011; 121: 120-31.
38. Ames PR, Batuca JR, Ciampa A, Iannaccone L, Delgado Alves J,. Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome. J Rheumatol 2010; 37: 2523-30.
39. Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM,. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol 2013; 33: 777-84.
40. Montiel-Manzano G, Romay-Penabad Z, Papalardo de Martinez E, Meillon-Garcia LA, Garcia-Latorre E, Reyes-Maldonado E, et al., In vivo effects of an inhibitor of nuclear factor-κB on thrombogenic properties of antiphospholipid antibodies. Ann N Y Acad Sci 2007; 1108: 540-53.
41. Zhang J, McCrae KR,. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. Blood 2005; 105: 1964-9.
42. Zhou H, Chen D, Xie H, Xia L, Wang T, Yuan W, et al., Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR-4/IRAKs pathway in THP-1 cells. Thromb Res 2012; 130: e229-35.
43. Charrier E, Cordeiro P, Cordeau M, Dardari R, Michaud A, Harnois M, et al., Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell Immunol 2012; 276: 114-21.
44. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-6.
45. Fan J, Frey RS, Malik AB,. TLR-4 signaling induces TLR-2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003; 112: 1234-43.
46. Laflamme N, Echchannaoui H, Landmann R, Rivest S,. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur J Immunol 2003; 33: 1127-38.
47. Gladigau G, Haselmayer P, Scharrer I, Munder M, Prinz N, Lackner K, et al., A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. PLoS One 2012; 7: e42176.
48. Arad A, Proulle V, Furie RA, Furie BC, Furie B,. β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 2011; 117: 3453-9.
49. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL,. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006; 65: 2-6.
50. Xie H, Sheng L, Zhou H, Yan J,. The role of TLR-4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Br J Haematol 2014; 164: 165-76.